Management of drug and alcohol withdrawal.
Kosten
Thomas R
TR
Departments of Psychiatry, Yale University School of Medicine, New Haven, Conn., USA. thomas.kosten@yale.edu
O'Connor
Patrick G
PG
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000437:Alcoholism; D000553:Ambulatory Care; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use; D010819:Physician's Role; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D019966:Substance-Related Disorders
D000316:Adrenergic alpha-Agonists; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D009292:Narcotic Antagonists; D009294:Narcotics; D001569:Benzodiazepines